South African Mutations of the CCR5 Coreceptor for HIV Modify Interaction With Chemokines and HIV Envelope Protein

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/QAI.0b013e3181e0c7b2PMID 20442662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

  2008cited by this paper
• Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.

  2008cited by this paper
• Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists

  2008cited by this paper
• The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin.

  2007cited by this paper
• Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.

  2007cited by this paper
• CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection.

  2006cited by this paper
• Protein sulfation analysis--A primer.

  2006cited by this paper
• Interaction of small molecule inhibitors of HIV-1 entry with CCR5.

  2006cited by this paper
• Structural and Molecular Interactions of CCR5 Inhibitors with CCR5*

  2006cited by this paper
• Biochemical and HIV-1 Coreceptor Properties of K26R, a New CCR5 Variant in China's Sichuan Population

  2005cited by this paper
• Chemokine receptor CCR5: insights into structure, function, and regulation.

  2004cited by this paper
• Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.

  2004cited by this paper
• HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors.

  2003cited by this paper
• Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development

  2003cited by this paper
• Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry

  2003cited by this paper
• Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors.

  2003cited by this paper
• G Protein-Dependent CCR5 Signaling Is Not Required for Efficient Infection of Primary T Lymphocytes and Macrophages by R5 Human Immunodeficiency Virus Type 1 Isolates

  2003cited by this paper
• Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin.

  2003cited by this paper
• Development of a high-throughput viral-free assay for the measurement of CCR5-mediated HIV/cell fusion.

  2003cited by this paper
• African-based CCR5 single-nucleotide polymorphism associated with HIV-1 disease progression.

  2002influential reference
• Novel mutations identified using a comprehensive CCR5-denaturing gradient gel electrophoresis assay

  2001influential reference
• Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6*

  2001cited by this paper
• Gulliver's travels in HIVland

  2001cited by this paper
• Characterization of Full-Length HIV Type 1 Subtype C Sequences from South Africa

  2001cited by this paper
• Is Galpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?

  2001cited by this paper
• Is Gα16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?

  2001cited by this paper
• A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.

  2000cited by this paper
• Alleles that may influence HIV-1 pathogenesis in Chinese subjects.

  1999cited by this paper
• Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5

  1999cited by this paper
• Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

  1999cited by this paper
• Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function*

  1999cited by this paper
• CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.

  1999cited by this paper
• Naturally Occurring CCR5 Extracellular and Transmembrane Domain Variants Affect HIV-1 Co-receptor and Ligand Binding Function*

  1999cited by this paper
• Multiple Charged and Aromatic Residues in CCR5 Amino-terminal Domain Are Involved in High Affinity Binding of Both Chemokines and HIV-1 Env Protein*

  1999influential reference
• Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.

  1999cited by this paper
• LD78β, A Non-allelic Variant of Human MIP-1α (LD78α), Has Enhanced Receptor Interactions and Potent HIV Suppressive Activity*

  1999cited by this paper
• The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.

  1999cited by this paper
• A Tyrosine-Rich Region in the N Terminus of CCR5 Is Important for Human Immunodeficiency Virus Type 1 Entry and Mediates an Association between gp120 and CCR5

  1998cited by this paper
• A high affinity gonadotropin-releasing hormone (GnRH) tracer, radioiodinated at position 6, facilitates analysis of mutant GnRH receptors.

  1998cited by this paper
• Chemokines: understanding their role in T-lymphocyte biology.

  1998cited by this paper
• Multiple Residues Contribute to the Inability of Murine CCR-5 To Function as a Coreceptor for Macrophage-Tropic Human Immunodeficiency Virus Type 1 Isolates

  1998cited by this paper
• Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry

  1998influential reference
• Alanine Substitutions of Polar and Nonpolar Residues in the Amino-Terminal Domain of CCR5 Differently Impair Entry of Macrophage- and Dualtropic Isolates of Human Immunodeficiency Virus Type 1

  1998cited by this paper
• Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.

  1998cited by this paper
• Co-receptors for HIV-1 entry.

  1997cited by this paper
• Novel alleles of the chemokine-receptor gene CCR5.

  1997cited by this paper
• Chemokine receptors and HIV

  1997cited by this paper
• Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1

  1997cited by this paper
• HIV-1 Entry and Macrophage Inflammatory Protein-1β-mediated Signaling Are Independent Functions of the Chemokine Receptor CCR5*

  1997cited by this paper
• Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.

  1997cited by this paper
• The extent of genetic variation in the CCR5 gene

  1997cited by this paper
• Molecular mechanism of desensitization of the chemokine receptor CCR‐5: receptor signaling and internalization are dissociable from its role as an HIV‐1 co‐receptor

  1997cited by this paper
• Interaction of Chemokine Receptor CCR5 with its Ligands: Multiple Domains for HIV-1 gp120 Binding and a Single Domain for Chemokine Binding

  1997cited by this paper
• Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity.

  1997cited by this paper
• Global distribution of the CCR5 gene 32-basepair deletion

  1997cited by this paper
• Identification of a major co-receptor for primary isolates of HIV-1

  1996influential reference
• Molecular cloning and functional expression of a new human CC-chemokine receptor gene.

  1996cited by this paper
• CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

  1996cited by this paper
• Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

  1996influential reference
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

  1996cited by this paper
• HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

  1996cited by this paper
• Molecular Cloning and Functional Characterization of a Novel Human CC Chemokine Receptor (CCR5) for RANTES, MIP-1β, and MIP-1α*

  1996cited by this paper
• A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

  1996cited by this paper
• Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP‐1α, MIP‐1β, and RANTES

  1996cited by this paper
• CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

  1996cited by this paper
• Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

  1996influential reference
• [8] Ligand binding and second-messenger assays for cloned Gq/G11-coupled neuropeptide receptors: The GnRH receptor

  1995cited by this paper
• The probable arrangement of the helices in G protein‐coupled receptors.

  1993cited by this paper

• Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer.

  2024cites this paper
• CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection

  2022cites this paper
• Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5

  2021cites this paper
• Genetic Polymorphisms in the Open Reading Frame of the CCR5 gene From HIV-1 Seronegative and Seropositive Individuals From National Capital Regions of India

  2019cites this paper
• Naturally occurring and synthetic constitutive-active cytokine receptors in disease and therapy.

  2019cites this paper
• Convergent evolution in human and domesticate adaptation to high-altitude environments

  2019cites this paper
• HIV-1 coreceptor CCR5: gene characterization and expression

  2014influential citation
• Receptor conformation and constitutive activity in CCR5 chemokine receptor function and HIV infection.

  2014cites this paper
• MUTATIONS IN C-C CHEMOKINE RECEPTOR TYPE FIVE ( CCR 5 ) IN SOUTH AFRICAN INDIVIDUALS

  2014cites this paper
• The Brugia malayi neuropeptide receptor-4 is activated by FMRFamide-like peptides and signals via Gαi.

  2014cites this paper
• Mutations in C-C chemokine receptor type 5 (CCR5) in South African individuals.

  2013cites this paper
• Constitutively Active CCR5 Chemokine Receptors Differ in Mediating HIV Envelope-dependent Fusion

  2013influential citation
• C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection☆

  2013cites this paper